Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ProStar Announces that a Global Fortune 500 Energy Company Adopts PointMan to Improve Refinery Maintenance Operations
-
Novo Nordisk A/S - share repurchase programme
-
Three Protocol Introduces Fraud-Resistant eCommerce Solutions, Pioneering Crypto as the Future of Payment
-
Bybit Türkiye Listed as a Crypto Asset Service Provider by the CMB
-
Sagexion Announces Launch with First Two Games: Meme Party and Ludo Sax
-
The Global Panda Partners 2024 Scheduled to Take Place in Chengdu by End of November
-
Oma Savings Bank Plc issues an unsecured senior-term bond of EUR 30 million as part of a bond program
-
Sports.com Expands Geographical Footprint, Launching in New Markets Across Asia
-
Luzhou Hosted The 3rd Global Geographical Indications Products Expo
-
Brookfield Global Infrastructure Securities Income Fund Announces Quarterly Distribution
-
Jeffs’ Brands: Fort Products Recognized by Amazon UK as a Key Account, Eligible for the Top Seller Program
-
Form 8.3 - AXA INVESTMENT MANAGERS: Rightmove plc
-
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
-
IDEX Biometrics extraordinary general meeting held on 23 Sep 2024
-
UAB Partnerystės projektai keturi 2024 first half financial statements
-
Discover the TTcoin (TC) Listing on XT
-
Form 8.3 - AXA INVESTMENT MANAGERS: REA Group Ltd
-
FTI Consulting Adds EY Global M&A Leader to Transactions Practice
-
Class 1 Nickel Provides Update on Dundonald South Nickel Sulphide Deposit and the Alexo-Dundonald Advanced Nickel Sulphide Project, Timmins, Canada
-
FTI Consulting Adds EY Global M&A Leader to Transactions Practice
-
VR Resources Closes Acquisition of Empire Properties in Northern Ontario and Commences Copper-Gold Exploration
-
The Distinguished Gentleman’s Drive Celebrates Its Fourth Year on Sunday, September 29, 2024
-
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
-
VitalHub Announces Strategic Hire to Accelerate Corporate Growth
-
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
-
Stardust Power Welcomes Paramita Das as Chief Strategy Officer and Senior Advisor to Chief Executive
-
Heritage Holding Closes Inaugural Fund with Support from Institutional Capital
-
Nova Leap Health Corp. to Present at the Planet MicroCap Showcase
-
AGF Investments Announces September 2024 Cash Distributions for Certain AGF ETFs and ETF Series
-
Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca
-
Middlefield Canadian Income PCC - Holding(s) in Company
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Dividend Declaration
-
Troilus Refiles Amended and Restated Third Quarter Financial Statements
-
Ipsen’s Kayfanda® (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare liver disease
-
Mr. Roger Rosmus, Founder & CEO Of Goliath To Present At Noble Capital Markets’ Basic Industries Emerging Growth Virtual Equity Conference, Wednesday September 25th, 2024
-
Mr. Roger Rosmus, Founder & CEO Of Goliath To Present At Noble Capital Markets’ Basic Industries Emerging Growth Virtual Equity Conference, Wednesday September 25th, 2024
-
uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease
-
Kraig Biocraft Laboratories Launches Spider Silk Production at Recently Completed Higher Capacity Facility
-
MEDIA ADVISORY - Canadian Emergency Preparedness and Climate Adaptation Convention: Major Events
-
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart)
-
Outbrain announces repurchase of remaining 2.95% Convertible Senior Notes due 2026
-
Central Iron Ore Limited: Drilling Results Finalised
-
Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan
-
Opthea Joins the S&P/ASX 300 Index
-
Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)
-
Meridian Launches Fourth Annual Small Business Big Impact Awards
-
Employ Inc. Appoints Joey Humke as Chief Revenue Officer
-
Orgenesis Announces Reverse Stock Split
-
Troilus Announces Enhanced Renewable Energy Capacity at the Troilus Site
